Laatste nieuws in bio
DNA Breakthrough Reveals Dogs Lived with Humans 5,000 Years Earlier Than Previously Known
Netherlands, Sunday, 29 March 2026.
Advanced genetic analysis technology has enabled scientists to identify 15,800-year-old bone remains as belonging to domesticated dogs, pushing back the timeline of human-canine companionship by 5,000 years. This represents a significant technological leap in archaeological DNA extraction capabilities, allowing researchers to analyze much older specimens than ever before possible. The discovery fundamentally reshapes our understanding of early domestication and demonstrates how cutting-edge biotechnology continues to rewrite ancient history.
Dutch Healthcare Startup Wins €1 Million at Major European Tech Conference
Enschede, Saturday, 28 March 2026.
OASYS NOW, a Netherlands-based company developing personalized medicine solutions for cardiology and rare diseases, secured the top €1 million prize at Slush 2024, Europe’s premier startup event held in Helsinki.
Dutch Startup Raises €1.7 Million to Bring Hospital-Grade Heart Testing to Your Living Room
Netherlands, Friday, 27 March 2026.
HeartEye’s breakthrough technology could revolutionize cardiac care by making professional 12-channel ECG recordings possible anywhere in under one minute. The funding from ROM InWest and tech industry veterans will accelerate market introduction of their wireless device, which enables general practitioners and nurses to perform hospital-quality heart diagnostics outside traditional medical settings. This innovation addresses a critical healthcare gap, as recent studies show AI-based ECG interpretation outperforms standard diagnosis methods with 99% specificity in detecting heart attacks. The portable solution promises earlier detection of heart conditions while reducing unnecessary hospital referrals, potentially saving lives and healthcare costs through more efficient cardiac monitoring accessibility.
Medical Device Giant Medtronic Acquires Dutch Startup Fortimedix Surgical
Netherlands, Thursday, 26 March 2026.
Global healthcare leader Medtronic successfully acquired Dutch medtech startup Fortimedix Surgical on December 1, 2025, marking the tenth exit for investor BVP’s health portfolio. The acquired company, now operating as Medtronic Articulating Technologies, specialized in laser technology for articulating surgical instruments used in minimally invasive procedures. This strategic move strengthens Medtronic’s position in the growing hysterectomy device market, valued at $4.3 billion and expected to reach $10.5 billion by 2033.
Dutch Scientists Replace Toxic Chemicals with Electricity to Make Pharmaceutical Building Blocks
Wageningen, Wednesday, 25 March 2026.
Wageningen University researchers have created a breakthrough electrochemical process that produces 2(5H)-furanone, a crucial building block for medicines and plastics, using only electricity and harmless salts instead of dangerous liquid bromine. The innovation eliminates the need to store toxic chemicals while converting agricultural waste into valuable pharmaceutical components. Their simple reactor design consumes less than 0.5% of the electricity used by a kettle, offering a safer and more sustainable path for chemical manufacturing that could revolutionize how Europe produces essential materials for drugs and industrial applications.
Startup Creates Brainless Organ Systems to End Animal Testing
Boston, Tuesday, 24 March 2026.
Bay Area biotech R3 Bio is engineering complete organ systems without brains to replace laboratory animals in pharmaceutical testing. The billionaire-backed company plans to create monkey organ ‘sacks’ first, then human versions for drug development. With over 60,000 primates used annually in US research and China’s 2020 export ban creating supply shortages, R3 Bio’s technology could revolutionize medical testing while addressing ethical concerns about animal experimentation.